neelakantan et al. biochemical pharmacology 2019 5-amino-1mq — 50mg | NNMT Inhibitor (NAD+ Axis) 5-AMINO-1MQ 30ML LIQUID (50MG/ML, 1500MG

Anti-Inflammatory & Gut Health Suppor May Protect the Brain Supports nerve regeneration and brain health

Approach Phase 2b trial arm Duration 24 weeks Review Point Week 12 and 24 Notes METAOD006 (OPTIONS) used 24 weeks at oral doses 0.25, 0.5, or 1 mg/day in 502 obese adults

It is important for heart and brain function, muscle movement, and many other body processes

However, it is not approved by the FDA nor has it been evaluated in late-stage, larger scale clinical trials

Precautions: The usual precautions for parenteral administration should be observed

Enhances energy expenditure at the cellular level, aiding in weight management